117 related articles for article (PubMed ID: 1360021)
1. The management of hyperthyroidism due to Graves' disease in the former USSR in 1991: results of a survey.
Gerasimov G; Judenitch O; Zdanova E; Jurieva N; Korostishevskaja I; Mushinskaja K; Dedov I; Glinoer D
J Endocrinol Invest; 1992; 15(7):513-7. PubMed ID: 1360021
[TBL] [Abstract][Full Text] [Related]
2. 2021 Asia-Pacific Graves' Disease Consortium Survey of Clinical Practice Patterns in the Management of Graves' Disease.
Parameswaran R; de Jong MC; Kit JLW; Sek K; Nam TQ; Thang TV; Khue NT; Aye TT; Tun PM; Cole T; Miller JA; Villa M; Khiewvan B; Sirinvaravong S; Sin YL; Muhammad R; Jap TS; Agrawal A; Rajput R; Fernando R; Sumanatilleke M; Suastika K; Shong YK; Lang B; Bartalena L; Yang SP;
Endocrine; 2023 Jan; 79(1):135-142. PubMed ID: 36129592
[TBL] [Abstract][Full Text] [Related]
3. The iodine perchlorate discharge test before and after one year of methimazole treatment of hyperthyroid Graves' disease.
Roti E; Minelli R; Gardini E; Bianconi L; Salvi M; Gavaruzzi G; Ugolotti G; Braverman LE
J Clin Endocrinol Metab; 1994 Mar; 78(3):795-9. PubMed ID: 8126159
[TBL] [Abstract][Full Text] [Related]
4. Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States.
Wartofsky L; Glinoer D; Solomon B; Nagataki S; Lagasse R; Nagayama Y; Izumi M
Thyroid; 1991; 1(2):129-35. PubMed ID: 1688014
[TBL] [Abstract][Full Text] [Related]
5. Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function.
Popoveniuc G; Sharma M; Devdhar M; Wexler JA; Carroll NM; Wartofsky L; Burman KD
Thyroid; 2010 Sep; 20(9):1015-8. PubMed ID: 20718680
[TBL] [Abstract][Full Text] [Related]
6. [Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
Escobar Jiménez F; Luna López V; Fernández Soto ML; Quezada Charneco M; Glinoer D
Med Clin (Barc); 1998 Sep; 111(6):205-10. PubMed ID: 9789225
[TBL] [Abstract][Full Text] [Related]
7. Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism.
Andrade VA; Gross JL; Maia AL
J Clin Endocrinol Metab; 1999 Nov; 84(11):4012-6. PubMed ID: 10566642
[TBL] [Abstract][Full Text] [Related]
8. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
9. The management of hyperthyroidism due to Graves' disease in Japan in 1988. The Japan Thyroid Association.
Nagayama Y; Izumi M; Nagataki S
Endocrinol Jpn; 1989 Apr; 36(2):299-314. PubMed ID: 2476301
[TBL] [Abstract][Full Text] [Related]
10. International differences in approaches to 131I therapy for Graves' disease: case selection and restrictions recommended to patients in Japan, Korea, and China.
Tominaga T; Yokoyama N; Nagataki S; Cho BY; Koh CS; Chen JL; Shi Y
Thyroid; 1997 Apr; 7(2):217-20. PubMed ID: 9133688
[TBL] [Abstract][Full Text] [Related]
11. A SURVEY OF CLINICAL PRACTICE PATTERNS IN MANAGEMENT OF GRAVES DISEASE IN THE MIDDLE EAST AND NORTH AFRICA.
Beshyah SA; Khalil AB; Sherif IH; Benbarka MM; Raza SA; Hussein W; Alzahrani AS; Chadli A
Endocr Pract; 2017 Mar; 23(3):299-308. PubMed ID: 27967219
[TBL] [Abstract][Full Text] [Related]
12. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
Andrade VA; Gross JL; Maia AL
J Clin Endocrinol Metab; 2001 Aug; 86(8):3488-93. PubMed ID: 11502768
[TBL] [Abstract][Full Text] [Related]
13. Laboratory tests for evaluating thyroid therapy.
Kabadi UM
Am Fam Physician; 1982 Sep; 26(3):183-8. PubMed ID: 6180620
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of Graves disease.
Streetman DD; Khanderia U
Ann Pharmacother; 2003; 37(7-8):1100-9. PubMed ID: 12841824
[TBL] [Abstract][Full Text] [Related]
15. A 2013 European survey of clinical practice patterns in the management of Graves' disease.
Bartalena L; Burch HB; Burman KD; Kahaly GJ
Clin Endocrinol (Oxf); 2016 Jan; 84(1):115-20. PubMed ID: 25581877
[TBL] [Abstract][Full Text] [Related]
16. Neonatal hyperthyroidism in infants of mothers previously thyroidectomized due to Graves' disease.
Borrás-Pérez MV; Moreno-Pérez D; Zuasnabar-Cotro A; López-Siguero JP
J Pediatr Endocrinol Metab; 2001; 14(8):1169-72. PubMed ID: 11592578
[TBL] [Abstract][Full Text] [Related]
17. The management of subclinical hyperthyroidism by thyroid specialists.
McDermott MT; Woodmansee WW; Haugen BR; Smart A; Ridgway EC
Thyroid; 2003 Dec; 13(12):1133-9. PubMed ID: 14751034
[TBL] [Abstract][Full Text] [Related]
18. Clinical practice. Graves' disease.
Brent GA
N Engl J Med; 2008 Jun; 358(24):2594-605. PubMed ID: 18550875
[No Abstract] [Full Text] [Related]
19. Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease.
Bogazzi F; Bartalena L; Campomori A; Brogioni S; Traino C; De Martino F; Rossi G; Lippi F; Pinchera A; Martino E
J Clin Endocrinol Metab; 2002 Oct; 87(10):4490-5. PubMed ID: 12364424
[TBL] [Abstract][Full Text] [Related]
20. [Hyperthyroidism].
Schott M
Internist (Berl); 2013 Mar; 54(3):315-26; quiz 327. PubMed ID: 23389325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]